Justin McCue, Ph.D.
Vice President, Chemistry, Manufacturing and Controls
Justin McCue, Ph.D. joined Omeros as our Vice President of Chemistry, Manufacturing and Controls (CMC) in September, 2018. Prior to joining Omeros, Dr. McCue headed the development of CAR T-cell and T-cell receptor (TCR) therapy manufacturing processes at Juno Therapeutics (now Celgene). Prior to Celgene, Dr. McCue was at Biogen between 2004 to 2017, in which he held various positions of increasing responsibility within CMC, including Director of Manufacturing Science, Director of Product Quality Management, and leading Biogen’s CMC activities for the multi-billion dollar drugs AVONEX® and PLEGRIDY®. He began his career in the biopharmaceutical division at Millipore. Dr. McCue earned his Ph.D. in chemical engineering at Massachusetts Institute of Technology (M.I.T.) after receiving a degree in chemical engineering from the University of California at Berkeley.